Adaptive Biotechnologies (ADPT) Price to Book (2019 - 2026)

Adaptive Biotechnologies has disclosed Price to Book across 8 years of filings, most recently posting 22.65 for Q2 2026.

• In Q2 2026, Price to Book rose 129.24% year-over-year to 22.65; the TTM figure through Jun 2026 stood at 22.65 (up 129.24% YoY), while the FY2025 annual figure was 11.1, up 153.9% from the prior year.
• Price to Book came in at 22.65 for Q2 2026 at Adaptive Biotechnologies, up from 9.88 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 22.65 in Q2 2026 to a low of 1.72 in Q1 2024.
• Average Price to Book over 5 years is 5.69, with a median of 3.19 recorded in 2023.
• Year-over-year, Price to Book plunged 73.12% in 2022 and jumped 346.78% in 2025.
• Over 5 years, Price to Book stood at 2.36 in 2022, then dropped by 2.11% to 2.31 in 2023, then jumped by 89.57% to 4.37 in 2024, then jumped by 153.9% to 11.1 in 2025, then jumped by 104.03% to 22.65 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 22.65 in Q2 2026, 9.88 in Q1 2026, and 11.1 in Q4 2025.